Literature DB >> 14555990

DroVav, the Drosophila melanogaster homologue of the mammalian Vav proteins, serves as a signal transducer protein in the Rac and DER pathways.

Idit Hornstein1, Mark A Mortin, Shulamit Katzav.   

Abstract

Mammalian Vav signal transducer proteins couple receptor tyrosine kinase signals to the activation of the Rho/Rac GTPases, leading to cell differentiation and/or proliferation. The unique and complex structure of mammalian Vav proteins is preserved in the Drosophila melanogaster homologue, DroVav. We demonstrate that DroVav functions as a guanine-nucleotide exchange factor (GEF) for DRac. Drosophila cells overexpressing wild-type (wt) DroVav exhibited a normal morphology. However, overexpression of a truncated DroVav mutant (that functions as an oncogene when expressed in NIH3T3 cells) results in striking changes in the actin cytoskeleton, resembling those usually visible following Rac activation. Dominant-negative DRac abrogated these morphological changes, suggesting that the effect of the truncated DroVav mutant is mediated by activation of DRac. In Drosophila cells, we find that stimulation of the Drosophila EGF receptor (DER) increases tyrosine phosphorylation of DroVav, which in turn associates with tyrosine-phosphorylated DER. In addition, the following results imply that DroVav participates in downstream DER signalling, such as ERK phosphorylation: (a) overexpression of DroVav induces ERK phosphorylation; and (b) 'knockout' of DroVav by RNA interference blocks ERK phosphorylation induced by DER stimulation. Unlike mammalian Vav proteins, DroVav was not found to induce Jnk phosphorylation under the experimental circumstances tested in fly cells. These results establish the role of DroVav as a signal transducer that participates in receptor tyrosine kinase pathways and functions as a GEF for the small RhoGTPase, DRac.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14555990     DOI: 10.1038/sj.onc.1207027

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  7 in total

1.  Phylogenetic conservation of the regulatory and functional properties of the Vav oncoprotein family.

Authors:  José R Couceiro; María D Martín-Bermudo; Xosé R Bustelo
Journal:  Exp Cell Res       Date:  2005-08-15       Impact factor: 3.905

2.  Molecular basis for failure of "atypical" C1 domain of Vav1 to bind diacylglycerol/phorbol ester.

Authors:  Tamas Geczy; Megan L Peach; Saïd El Kazzouli; Dina M Sigano; Ji-Hye Kang; Christopher J Valle; Julia Selezneva; Wonhee Woo; Noemi Kedei; Nancy E Lewin; Susan H Garfield; Langston Lim; Poonam Mannan; Victor E Marquez; Peter M Blumberg
Journal:  J Biol Chem       Date:  2012-02-18       Impact factor: 5.157

Review 3.  Group choreography: mechanisms orchestrating the collective movement of border cells.

Authors:  Denise J Montell; Wan Hee Yoon; Michelle Starz-Gaiano
Journal:  Nat Rev Mol Cell Biol       Date:  2012-10       Impact factor: 94.444

4.  A Conserved GEF for Rho-Family GTPases Acts in an EGF Signaling Pathway to Promote Sleep-like Quiescence in Caenorhabditis elegans.

Authors:  Amanda L Fry; Jocelyn T Laboy; Huiyan Huang; Anne C Hart; Kenneth R Norman
Journal:  Genetics       Date:  2016-01-22       Impact factor: 4.562

5.  Dynein light chain 1 functions in somatic cyst cells regulate spermatogonial divisions in Drosophila.

Authors:  Prakash Joti; Anindya Ghosh-Roy; Krishanu Ray
Journal:  Sci Rep       Date:  2011-11-30       Impact factor: 4.379

6.  An active form of Vav1 induces migration of mammary epithelial cells by stimulating secretion of an epidermal growth factor receptor ligand.

Authors:  Julie L Wilsbacher; Sheri L Moores; Joan S Brugge
Journal:  Cell Commun Signal       Date:  2006-05-18       Impact factor: 5.712

7.  Vav independently regulates synaptic growth and plasticity through distinct actin-based processes.

Authors:  Hyun Gwan Park; Yeongjin David Kim; Eunsang Cho; Ting-Yi Lu; Chi-Kuang Yao; Jihye Lee; Seungbok Lee
Journal:  J Cell Biol       Date:  2022-08-17       Impact factor: 8.077

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.